Invivyd, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $53.4M | $25.4M | $0 | — | — |
| Selling, general & administrative | $66.9M | $63.4M | $49.1M | $47.0M | $36.5M |
| Research and development | $38.3M | $137.3M | $158.7M | $179.2M | $182.9M |
| Operating expenses | $109.0M | $202.3M | $212.8M | $248.0M | $226.9M |
| Operating income | -$55.6M | -$176.9M | -$212.8M | -$248.0M | -$226.9M |
| Income tax expense | $0 | $0 | $0 | $0 | $0 |
| Net income | -$52.5M | -$169.9M | -$198.6M | -$241.3M | -$226.8M |
| Balance Sheet | |||||
| Cash and equivalents | $226.7M | $69.3M | $200.6M | $92.1M | $542.2M |
| Current assets | $247.5M | $100.7M | $224.9M | $376.9M | $616.7M |
| Total assets | $276.9M | $129.5M | $229.2M | $383.2M | $620.1M |
| Current liabilities | $34.2M | $62.0M | $50.3M | $25.0M | $62.1M |
| Total liabilities | $35.3M | $62.0M | $51.7M | $27.2M | $62.1M |
| Stockholders' equity | $241.5M | $67.5M | $177.5M | $356.0M | $558.0M |
| Cash Flow Statement | |||||
| Cash from operations | -$58.1M | -$170.5M | -$173.2M | -$220.0M | -$184.7M |
| Depreciation and amortization | $755,000 | $1.5M | $480,000 | $41,000 | $1,000 |
| Stock-based compensation | $11.6M | $19.8M | $18.7M | $21.6M | $17.8M |
| Capital expenditure | $155,000 | $140,000 | $615,000 | $1.7M | $84,000 |
| Free cash flow | -$58.3M | -$170.6M | -$173.8M | -$221.7M | -$184.8M |
| Share repurchases | — | $0 | $1,000 | $4,000 | $0 |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 294.6M · Free float 82.9%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.